Endovia Health Sciences Inc. (EDVA)
NYSE: EDVAConsumer StaplesBeverages (Production/Distribution)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EDVA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.64M
- EPS (TTM)
- -$21.94
- Dividend yield
- None
- 52-week range
- 0.134 – 6.76
- Day range
- 0.1436 – 0.154
- Volume / Avg
- 262.63K / 2.56M
- Beta
- —
- Shares outstanding
- 11.41M
52-week range
EDVA stock today
Shares of Endovia Health Sciences (EDVA) finished lower on Nov 20 at $0.1436, a drop of 0.49% or $0.0007 per share, versus the S&P 500's 3.70% decline. Trading was light, with 262.63K shares changing hands, about 10% of the average daily volume. At this level, EDVA sits near the bottom of its 52-week range of $0.134 to $6.76: 97.9% below the high and 7.2% above the low.
Endovia Health Sciences has posted a net loss over the last twelve months (EPS of -$21.94), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Endovia Health Sciences
Company profileEndovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution.
- Sector
- Consumer Staples
- Industry
- Beverages (Production/Distribution)
- CEO
- Mr. Brady Cobb
- Headquarters
- Fort Lauderdale, FL
- Employees
- 1
- IPO year
- 2021
- Website
- EndoviaSciences.com
Financial highlights
Full financialsIn fiscal 2025, Endovia Health Sciences generated $73,066 in revenue, down 90.9% from fiscal 2024, its first annual decline since 2024. Endovia Health Sciences reported a net loss of $25.2 million, compared with a loss of $23.8 million a year earlier. Gross margin was 23.1% (up from -15.0%) and operating margin -19415.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $73.07K | $801.27K | $18.85M | $18.09M | $11.32M |
| Growth | -90.88% | -95.75% | +4.22% | +59.84% | +391.97% |
| Net income | $-25.23M | $-23.76M | $-21.00M | $-21.69M | $-29.05M |
| EPS (diluted) | $-11.97 | $-17.68 | $-19.79 | $-0.58 | $-1.02 |
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 18, 2026
- EPS actual vs est.
- $-18.04 vs —
Endovia Health Sciences peers
Consumer Staples sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IPSTIP Strategy Holdings Inc. | 1.47 | -9.29% | $1.46M | vs EDVA |
| YHCLQR House Inc. | 1.59 | -12.00% | $2.07M | vs EDVA |
| AMSSAMASS Brands Inc. | 0.215 | -4.44% | $2.50M | vs EDVA |
| IBGInnovation Beverage Group Limited | 0.6625 | -1.13% | $2.80M | vs EDVA |
| CCUCompania Cervecerias Unidas S.A. | 9.79 | -1.04% | — | vs EDVA |
| EPSMEpsium Enterprise Limited Class A | 0.5601 | -13.16% | $7.52M | vs EDVA |
| WVVIWillamette Valley Vineyards Inc. | 1.66 | -4.39% | $8.26M | vs EDVA |
| SRXHSRX Global Inc. | 0.80 | -22.33% | $16.15M | vs EDVA |
Indexes, lists and sector
Largest Consumer Staples stocks
Endovia Health Sciences stock FAQ
What is Endovia Health Sciences's stock price today?
EDVA last traded at $0.1436 as of Nov 20, 4:00 PM EST, down 0.49% on the day. Prices are delayed at least 15 minutes.
Who is Endovia Health Sciences's CEO?
Mr. Brady Cobb is the chief executive officer of Endovia Health Sciences Inc., which has about 1 employees.
What is the EDVA 52-week high?
The 52-week high for EDVA is $6.76 and the 52-week low is $0.134. The stock is currently 97.9% below its high.